| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.82B | 93.73B | 86.78B | 93.31B | 85.31B | 71.93B |
| Gross Profit | 25.79B | 24.63B | 22.15B | 19.49B | 17.60B | 14.21B |
| EBITDA | 7.60B | 7.32B | 6.26B | 5.23B | 4.41B | 3.19B |
| Net Income | 5.83B | 7.80B | 4.49B | 5.00B | 2.25B | 2.72B |
Balance Sheet | ||||||
| Total Assets | 123.12B | 129.53B | 118.54B | 79.99B | 104.86B | 97.46B |
| Cash, Cash Equivalents and Short-Term Investments | 13.68B | 16.93B | 10.53B | 10.75B | 17.49B | 15.92B |
| Total Debt | 393.00M | 200.00M | 199.00M | 2.14B | 5.65B | 7.71B |
| Total Liabilities | 75.88B | 81.86B | 75.36B | 44.25B | 73.76B | 67.57B |
| Stockholders Equity | 46.76B | 47.21B | 42.51B | 35.21B | 30.39B | 29.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.46B | 2.02B | -3.09B | 4.60B | 3.63B |
| Operating Cash Flow | 0.00 | 8.07B | 2.54B | -731.00M | 4.97B | 4.14B |
| Investing Cash Flow | 0.00 | 793.00M | -88.00M | -1.07B | 1.13B | -1.57B |
| Financing Cash Flow | 0.00 | -2.90B | -3.46B | -4.82B | -3.30B | -1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥38.40B | 8.57 | ― | 1.78% | -0.94% | 51.59% | |
79 Outperform | ¥96.79B | 14.20 | ― | 3.38% | 10.74% | -26.50% | |
73 Outperform | ¥315.78B | 21.53 | ― | 1.68% | 7.95% | 28.36% | |
73 Outperform | ¥55.23B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.20B | 15.26 | ― | 3.17% | 5.95% | 23.97% | |
61 Neutral | ¥154.50B | 9.98 | ― | 2.42% | 9.74% | 6.48% |